News & Analysis

Latest content

SCOTUS turns down much-watched ‘skinny label’ appeal in blow to generic drug companies

The decision, leaving in place a polarising Federal Circuit decision, has significant implications for life sciences IP strategies

16 May 2023

Patent holders flee Delaware as disclosure orders continue to bite

The latest IAM-Docket Navigator report takes a deep dive into filing trends, breaking cases down by technology centre and top parties, following Judge Colm Connolly’s transparency requirements

15 May 2023

UPC system experiencing severe problems as patentees race to opt out their rights

Everything you need to know about the debacle with the new court’s Case Management System

15 May 2023

AI data mining proposal; Auto IP USA; cellular patent pools; Netlist interview; WiLAN revenues; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days

14 May 2023

It is time for life sciences IP professionals to embrace change in the industry

Opinion: Pharma and biotech patent professionals must adapt to new challenges and opportunities

13 May 2023

Relationship-building drives patent dealmaking in a complex licensing environment

As we reveal the agenda for IAM Live: Patent Transactions 2023, we asked patent dealmakers to tell their stories of relationship-building at IP conferences

12 May 2023

Biogen’s European exclusivity boost is silver lining following US Tecfidera disaster

Following a catastrophic loss of exclusivity stateside, the company has received a boost in the EU

12 May 2023

Report urges companies to hunt for more value from their patents

PatSnap’s “State of IP” report reveals intelligence about patent value, monetisation strategies, IP department budgets and more

11 May 2023

Gilead scores major victory in controversial $1 billion dispute with US government

Delaware jury rules against the federal government in a big-money patent infringement suit being closely watched by policymakers.

11 May 2023

Even the best chief IP officers don’t get everything right

In the 20 years IAM has been around, we have seen some brilliant individuals make a major difference to the companies that employ them. But they often leave a problem behind

11 May 2023

Unlock unlimited access to all IAM content